Toronto Dominion Bank
BIIB icon

Toronto Dominion Bank’s Biogen BIIB Stock Holding History

Toronto Dominion Bank’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,100
Closed -$733K – 1468
2019
Q1 		$733K Buy
3,100
+2,400
+343% +$756K ﹤0.01% 1046
2018
Q4 		$211K Buy
+700
New +$223K ﹤0.01% 1095
2018
Q1 		– Sell
-21,500
Closed -$6.85M – 1305
2017
Q4 		$6.85M Buy
+21,500
New +$6.9M 0.02% 438

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Toronto Dominion Bank's BIIB Position: Q2 2026 in Review

Toronto Dominion Bank increased its Biogen (BIIB) stake by 3.2% in Q2 2026, buying an estimated $264K and bringing the position to 44,752 shares worth $9.67M. The position accounts for 0.01% of the portfolio, ranked #702.

Toronto Dominion Bank first reported a position in BIIB in Q4 2013 and has held it in 51 quarters since. The position peaked at $66.1M in Q1 2015. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Toronto Dominion Bank held 44,752 shares of Biogen worth $9.67M as of Q2 2026.
  • Toronto Dominion Bank bought 1,381 Biogen shares in Q2 2026, an estimated $264K.
  • Biogen made up 0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #702 holding.
  • Toronto Dominion Bank first reported a position in Biogen in Q4 2013 and has held it in 51 quarters since.
  • Toronto Dominion Bank's Biogen position peaked at $66.1M in Q1 2015.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.